In CKD–mineral and bone disorder, dysregulated FGF23, klotho, vitamin D, and PTH cause progressive hyperphosphatemia, hypercalcemia, and hyperparathyroidism and contribute to the increased cardiovascular risk in patients with renal failure [144]. This evidence concerns the gene PTH and chronic kidney disease.